Skip to Main content Skip to Navigation
Journal articles

Le marché des antipaludéens: entre régulation et défaillance

Abstract : Faced with the rise of resistance to monotherapies, the artemisinine-combination therapies (ACTs) have become the early�2000s, the golden standard in the fight against plasmodium falciparum malaria. Because of the need to substitute these therapies to older drugs and given the vastly more expensive ACTs, World Health Organization has established itself in global prescriber, enacting, on the one hand, health policy recommendations towards the endemic countries and organizing, on the other, a global supply chain. This article analyzes the disconnection that results from this model of governance, between the national and global levels and the consequences on the health status of malarious countries.
Complete list of metadata
Contributor : Elisabeth Lhuillier Connect in order to contact the contributor
Submitted on : Monday, February 6, 2017 - 1:50:41 PM
Last modification on : Tuesday, August 2, 2022 - 5:56:10 PM

Links full text




Fabienne Orsi, Jean-Benoît Zimmermann. Le marché des antipaludéens: entre régulation et défaillance. Mondes en Développement, De Boeck, 2015, 170 (2), pp.21-40. ⟨10.3917/med.170.0021⟩. ⟨hal-01457306⟩



Record views